The timing of antidepressant effects: a comparison of diverse pharmacological and somatic treatments

Machado-Vieira, Rodrigo, Baumann, Jacqueline, Wheeler-Castillo, Cristina, Latov, David, Henter, Ioline D., Salvadore, Giacomo, Zarate, Carlos A.·2010·Pharmaceuticals

DOI 10.3390/ph3010019

Cited by (263)

Items 101–200 of 263

Total Sleep Deprivation Followed by Bright Light Therapy as Rapid Relief for Depression: A Pragmatic Randomized Controlled Trial
Ioannou, Michael, Szabó, Zoltán, Widmark-Jensen, Mats, Vyrinis, Georgios, Karlsson, Christopher, Steingrimsson, Steinn · 2021 · Frontiers in Psychiatry
Fabrication of a Controlled-Release Core-Shell Floating Tablet of Ketamine Hydrochloride Using a 3D Printing Technique for Management of Refractory Depressions and Chronic Pain
Tahmineh Karami, Emad Ghobadi, Mohammad Akrami, Ismaeil Haririan · 2024 · Polymers
Update on the assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form-2 (ATHF-SF2)
Harold A. Sackeïm, Scott T. Aaronson, Mark T. Bunker, Charles R. Conway, Mark S. George, Hamish McAllister-Williams, Joan Prudic, Michael E. Thase, Allan Hunter Young, A. John Rush · 2024 · Journal of Psychiatric Research
Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review
Sarah Kuburi, Anne-Marie Di Passa, Vanessa K. Tassone, Raesham Mahmood, Aleksandra Lalovic, Karim Shiraz Ladha, Katharine Dunlop, Sakina J. Rizvi, Ilya Demchenko, Venkat Bhat · 2022 · Chronic Stress
The Melanocortin System: A Promising Target for the Development of New Antidepressant Drugs
Dmitrii D. Markov, Oleg V. Dolotov, Igor A. Grivennikov · 2023 · International Journal of Molecular Sciences
Unveiling behavioral and molecular neuroadaptations related to the antidepressant action of cannabidiol in the unpredictable chronic mild stress model
María S. García‐Gutiérrez, Daniela Navarro, Amaya Austrich-Olivares, Jorge Manzanares · 2023 · Frontiers in Pharmacology
Whole Person Modeling: a transdisciplinary approach to mental health research
Daniel Felsky, Alyssa Cannitelli, Jon Pipitone · 2023 · Discover Mental Health
Liposomes Coloaded with Elacridar and Tariquidar To Modulate the P-Glycoprotein at the Blood–Brain Barrier
Rita Nieto-Montesinos, Arnaud Béduneau, Alf Lamprecht, Yann Pellequer · 2015 · Molecular Pharmaceutics
Effects of desvenlafaxine versus placebo on MDD symptom clusters: A pooled analysis
Martin A. Katzman, Xuemei Wang, Dalia Wajsbrot, Matthieu Boucher · 2020 · Journal of Psychopharmacology
Schedule 1 barriers to research in the UK: An in-depth qualitative analysis
Annie Howard, Joanna Caroline Neill, Anne Katrin Schlag, Charlotte Lennox · 2021 · Drug Science Policy and Law
Antidepressant effects of ershiwei roudoukou pills and its active ingredient Macelignan: Multiple mechanisms involving oxidative stress, neuroinflammation and synaptic plasticity
Yanli Wang, Lei Chen, Xiao-Lin Zhong, Qingshan Liu, Wenqiang Li, Yong Cheng, Yang Du · 2025 · Translational Psychiatry
Frontal cortex genetic ablation of metabotropic glutamate receptor subtype 3 (mGlu3) impairs postsynaptic plasticity and modulates affective behaviors
Max E. Joffe, Chiaki I. Santiago, Sheryl Anne D. Vermudez, Nicole M. Fisher, Shalini Dogra, Colleen Marie Niswender, Peter Jeffrey Conn · 2021 · Neuropsychopharmacology
Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial report
Charles R. Conway, Augustus John Rush, Scott T. Aaronson, Mark T. Bunker, Charles Gordon, Mark S. George, Patricio Riva‐Posse, Rebecca M. Allen, Ziad H. Nahas, Christopher L. Kriedt et al. · 2025 · The International Journal of Neuropsychopharmacology
Insights into the neurobiology of suicidality: explicating the role of glutamatergic systems through the lens of ketamine
Adem Can, Jules Mitchell, Megan Dutton, Maxwell R. Bennett, Daniel Francis Hermens, Jim Lagopoulos · 2023 · Psychiatry and Clinical Neurosciences
The efficacy of zuranolone versus placebo in postpartum depression and major depressive disorder: a systematic review and meta-analysis
Mackenzie Winslow, Emily White, Suzanne J. Rose, Elijah A.J. Salzer, Eric C. Nemec · 2024 · International Journal of Clinical Pharmacy
Clinical Utility of Zuranolone for Postpartum Depression: A Narrative Review
Athanasia Giannopoulos, Joshna Singh, Kristina M. Deligiannidis · 2025 · Neuropsychiatric Disease and Treatment
Antidepressant use and risk of self-harm among people aged 40 years or older: A population-based cohort and self-controlled case series study
Yi Chai, Hao Luo, Kenneth K. C. Man, Wallis C. Y. Lau, Sherry Kit Wa Chan, Paul S. F. Yip, Ian Chi Kei Wong · 2022 · The Lancet Regional Health - Western Pacific
The expression of agmatinase manipulates the affective state of rats subjected to chronic restraint stress
Shi Fang Yan, Chang Shui Xu, Mengli Yang, Huiqiang Zhang, Cheng Ye, Zeping Xue, Zecong He, Tiantian Wang, Shangying Bai, Gang Wang et al. · 2023 · Neuropharmacology
Antidepressant and anxiolytic efficacy of single, chronic and concomitant use of vortioxetine, dapoxetine and fluoxetine in prenatally stressed rats
Piotr Ratajczak, Krzysztof Kus, Tomasz Zaprutko, Mikołaj Szczepański, Sandra Rusowicz, Elżbieta Nowakowska · 2019 · Acta Neurobiologiae Experimentalis
Effect of pharmacological manipulations on Arc function
Dina W. Yakout, Nitheyaa Shree Ramesh, Angela M. Mabb · 2020 · Current Research in Pharmacology and Drug Discovery
A Multidisciplinary Hypothesis about Serotonergic Psychedelics. Is it Possible that a Portion of Brain Serotonin Comes From the Gut?
Noémi Császár-Nagy, Petr Bob, István Bókkon · 2022 · Journal of Integrative Neuroscience
Major depressive disorder and bistability in an HPA-CNS toggle switch
Ben Ron Mizrachi, Avichai Tendler, Omer Karin, Tomer Milo, Dafna Haran, Avi Mayo, Uri S. Alon · 2023 · PLoS Computational Biology
Therapeutic potential of psychedelics: History, advancements, and unexplored frontiers
Juliana Marino Maia, Bruna Stefane Alves de Oliveira, Luiz G.S. Branco, Renato Nery Soriano · 2024 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Neuroimaging Studies of Antidepressant Placebo Effects: Challenges and Opportunities
Vanessa M Brown, M. Peciña · 2019 · Frontiers in Psychiatry
Depressive Disorder With Panic Attacks After Replacement of an Intrauterine Device Containing Levonorgestrel: A Case Report
René Zeiss, Carlos Schönfeldt‐Lecuona, Maximilian Gahr, Heiko Graf · 2020 · Frontiers in Psychiatry
Kétamine, psilocybine, et antidépresseurs d'action rapide : de nouvelles promesses pour la psychiatrie?
Hugo Bottemanne, Anne Claret, Philippe Fossati · 2020 · L Encéphale
Involvement of dorsal raphe nucleus serotonergic systems in social approach-avoidance behaviour and in the response to fluoxetine treatment in peri-adolescent female BALB/c mice
Jennyfer M. Payet, Kira-Elise Wilson, Adrian M. Russo, Anthony Angiolino, William Kavanagh-Ryan, Stephen Kent, Christopher A. Lowry, Matthew William Hale · 2021 · Behavioural Brain Research
Dexmedetomidine in the Treatment of Depression: An Up-to-date Narrative Review
Tamadhir Al-Mahrouqi, Mohammed Al‐Alawi, Rafael C. R. Freire · 2023 · Clinical Practice and Epidemiology in Mental Health
The interplay between 5-HT2C and 5-HT3A receptors in the dorsal periaqueductal gray mediates anxiety-like behavior in mice
Luana Tenorio Lopes, Lucas Canto‐de‐Souza, Daniela Baptista‐de‐Souza, Rimenez Rodrigues de Souza, Ricardo Luiz Nunes‐de‐Souza, Azair Canto‐de‐Souza · 2021 · Behavioural Brain Research
The effects of intramuscular administration of scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled trial
Jingjing Zhou, Jian Yang, Xuequan Zhu, Tarek Zghoul, Lei Feng, Runsen Chen, Gang Wang · 2020 · Therapeutic Advances in Psychopharmacology
Sexually Dimorphic Behavioral Profile in a Transgenic Model Enabling Targeted Recombination in Active Neurons in Response to Ketamine and (2R,6R)-Hydroxynorketamine Administration
David P. Herzog, Ratnadevi M. Mellema, Floortje Remmers, Beat Lutz, Marianne B. Müller, Giulia Treccani · 2020 · International Journal of Molecular Sciences
Evaluation of antidepressant activity of ethanolic extract of Mimosa pudica in swiss albino mice
Sanat Udyavar, Sharath Kumar K, Mohandas Rai, H N Gopalakrishna, R Chandrashekar, Sowmya · 2021 · Indian Journal of Pharmacy and Pharmacology
A Southeast Asian expert consensus on the management of major depressive disorder with suicidal behavior in adults under 65 years of age
Kok Yoon Chee, Nalini Muhdi, Nor Hayati Ali, Nurmiati Amir, Carmina Bernardo, Lai Fong Chan, Roger Ho, Pichai Ittasakul, Patanon Kwansanit, Melissa Paulita V. Mariano et al. · 2022 · BMC Psychiatry
Precision Medicine in Depression: The Role of Proteomics and Metabolomics in Personalized Treatment Approaches
Mohamad Houssein Jaber, Hamza Kahwaji, Sirine Nasr, Reine Baz, Yong‐Ku Kim, Marc Fakhoury · 2024 · Advances in experimental medicine and biology
Personalized psychiatry with human iPSCs and neuronal reprogramming
Cédric Bardy, Zarina Greenberg, Seth W. Perry, Júlio Licinio · 2019 · Elsevier eBooks
Symptom monitoring improves physical and emotional outcomes during menopause: a randomized controlled trial
Robin Andrews, Bev John, Deborah Lancastle · 2023 · Menopause The Journal of The North American Menopause Society
Safety of and response to electroconvulsive therapy during pregnancy: Results from population‐based nationwide registries
Tor Arnison, Olof Rask, Axel Nordenskjöld, Pouya Movahed · 2023 · Acta Psychiatrica Scandinavica
The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine
Dongsun Park, Gwangho Lee, Won-Gyu Lee, B.S. Kim, Yoonji Lee, Ji‐Woon Kim · 2025 · Molecular Psychiatry
The Mechanisms Underlying the Pharmacological Effects of GuiPi Decoction on Major Depressive Disorder based on Network Pharmacology and Molecular Docking
Li‐Yuan Chen, Tianyuan Ye, Xiaolong Wang, Lu Han, Tongxing Wang, Dongmei Qi, Xiaorui Cheng · 2022 · Combinatorial Chemistry & High Throughput Screening
Do Antidepressants Worsen COPD Outcomes in Depressed Patients with COPD?
Alan G. Kaplan · 2024 · Pulmonary Therapy
Dissecting the molecular mechanisms underlying the antidepressant activities of herbal medicines through the comprehensive review of the recent literatures
Yilu Sun, Jia Zhao, Jianhui Rong · 2022 · Frontiers in Psychiatry
Role of the Intestinal Microbiota in the Genesis of Major Depression and the Response to Antidepressant Drug Therapy: A Narrative Review
Tiziana Mundula, Simone Baldi, Elisabetta Gerace, Amedeo Amedei · 2023 · Biomedicines
Noninvasive Brain Stimulation Techniques for Treatment-Resistant Depression
Andrea Boscutti, Juliana Mendonca De Figueiredo, Dana Razouq, Nicholas Murphy, Raymond Cho, Sudhakar Selvaraj · 2023 · Psychiatric Clinics of North America
Introduction
Yiru Fang, Ruizhi Mao · 2019 · Advances in experimental medicine and biology
Registered clinical trials investigating ketamine and esketamine for treatment-resistant depression: A systematic review
Madeline Brendle, Anya Ragnhildstveit, Matthew A. Slayton, Leo Smart, Sarah R. Cunningham, Mackenzie H. Zimmerman, Paul Seli, Michael Santo Gaffrey, Lynnette A. Averill, Reid J. Robison · 2023 · Journal of Psychedelic Studies
Role of Biosynthesis and Catabolism of Neurotransmitters in Drug Discovery for Anxiety and Depression
Ashish Suresh Patil, Summon Koul · 2024 · Current Pharmaceutical Design
Cognitive effects, pharmacokinetics, and safety of zuranolone administered alone or with alprazolam or ethanol in healthy adults in a phase 1 trial
Joi Dunbar, David P. Walling, Howard A Hassman, Rakesh K. Jain, Andy Czysz, Indrani M. Nandy, Victor O. Ona, Margaret K Moseley, Seth N. Levin, Paul T. Maruff · 2024 · Journal of Psychopharmacology
Unequal access? Use of sickness absence benefits by precariously employed workers with common mental disorders: a register-based cohort study in Sweden
Julio César Hernando Rodríguez, Nuria Matilla Santander, Chantelle Murley, Katrina Julia Blindow, Signild Kvart, Melody Almroth, Bertina Kreshpaj, Emelie Thern, Kathryn Badarin, Carles Muntaner et al. · 2023 · BMJ Open
Novel treatments of depression: bridging the gap in current therapeutic approaches
Amit Jagtiani · 2024 · Exploration of neuroscience
Implementation of clinical guidelines in specialized palliative care—results from a national improvement project: A national register-based study
Leslye Rojas-Concha, Maiken Bang Hansen, Mathilde Adsersen, Morten Aagaard Petersen, Mogens Grøenvold · 2023 · Palliative Medicine
Interactions between whole-body heating and citalopram on body temperature, antidepressant-like behaviour, and neurochemistry in adolescent male rats
Matthew William Hale, Jodi L. Lukkes, Kathleen F. Dady, Kyle J. Kelly, Evan David Paul, David Glenn Smith, Jared D. Heinze, Charles L. Raison, Christopher A. Lowry · 2018 · Behavioural Brain Research
Simultaneous quantification of vortioxetine, fluoxetine and their metabolites in rat plasma by UPLC–MS/MS
Qiong Wang, Zhe Chen, Dingwen Chen, Shunbin Luo, Lingping Xie · 2020 · Biomedical Chromatography
Discovery of antidepressant active compounds from Polygala tenuifolia Willd.: An integrated multitarget screening strategy combining network pharmacology with cell membrane chromatography coupled to high performance liquid chromatography
Minghui Liu, Jiaxin Yin, Rui Sun, Jie Yong, Xiao Han, Wanjiao Wang, Yu Wang, Menglei Song, Tong Wu, Shengli Han et al. · 2025 · Journal of Ethnopharmacology
Psilocybin has a narrow therapeutic window as an antidepressant treatment
Lenka Seillier, Barbora Čechová, Alexandre Seillier, Romana Šlamberová · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Pharmacology and Therapeutics
Sharon Rees · 2020 · Elsevier eBooks
The rapid‐onset antidepressant effect of ketamine: More surprises?
Robert B. Raffa, Joseph V. Pergolizzi, Robert Taylor · 2017 · Journal of Clinical Pharmacy and Therapeutics
Role of transcranial direct current stimulation in bipolar depression: A case report
Sachin Pradeep Baliga, Vanteemar Sathyanarayana Sreeraj, Rujuta Ulhas Parlikar, Dev Rai, Harleen Chhabra, Vijay Kumar, Ganesan Venkatasubramanian · 2019 · Asian Journal of Psychiatry
Disentangling causal relationships between inflammatory markers and depression: a bidirectional Mendelian randomization analysis
Christina Dardani, James Yarmolinsky, Jamie W. Robinson, Jie Zheng, George Davey Smith, Sarah Jane Lewis, Lindsey Isla Sinclair · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
Phosphoproteomics implicates glutamatergic and dopaminergic signalling in the antidepressant-like properties of the iron chelator deferiprone
Volkan Uzungil, Sandra Luza, Carlos Opazo, Isaline Mees, Shanshan Li, Ching‐Seng Ang, Nicholas A. Williamson, Ashley Ian Bush, Anthony John Hannan, Thibault Renoir · 2024 · Neuropharmacology
Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression
Joshua M. Poulin, Gregory E. Bigford, Krista L. Lanctôt, Peter Giacobbe, Ayal Schaffer, Mark Sinyor, Jennifer S. Rabin, Mario Masellis, Amit Singnurkar, Christopher B. Pople et al. · 2024 · Trials
Early Improvement with Vortioxetine Predicts Response and Remission: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan
Takeshi Inoue, Shinji Fujimoto, Tatsuro Marumoto, T Kitagawa, Kazuyuki Ishida, Tadashi Nakajima, Yoshiya Moriguchi, Keita Fujikawa, Koichiro Watanabe · 2021 · Neuropsychiatric Disease and Treatment
Treatment patterns and decision drivers to discharge patients with depression hospitalised for acute suicidal ideation in Europe
Ute Lewitzka, Joana Anjo, Tiina Annus, Stephane Borentain, Kirsty Hope, Andrew Major, Marguerite O’Hara, Maurizio Pompili · 2022 · Journal of Affective Disorders
Not immune to stress: LBP’s link to depression
Rachel M. Rahn, Conor M. Liston · 2023 · Immunity
Patient characteristics, validity of clinical diagnoses and Outcomes Associated with Suicidality in Inpatients with Symptoms of Depression (OASIS-D): design, procedures and outcomes
Viktor Benjamin Nöhles, Felix Bermpohl, Peter Falkai, Christine Reif-Leonhard, Frank Jessen, Mazda Adli, Christian Otte, Andreas Meyer‐Lindenberg, Michael Bauer, Kerstin Rubarth et al. · 2023 · BMC Psychiatry
Major Depressive Disorder With Psychiatric Emergency in Hong Kong: A Review and Practice Recommendation of the Asian Association of Neuropsychopharmacology
Ho‐Bun Lam, Tak Lam Lo, Kwok Leung Au Yeung, Ngo Cheung, Eric F.C. Cheung, Chi Kin Fu, Chun Lam, Yiu Ki Lee, Ronnie Sze‐Yuan Pao, Wing Kuen Sung et al. · 2025 · Asia-Pacific Psychiatry
Novel psychedelic interventions for post-traumatic stress disorder and their promise for precision medicine
Charles Dodds, Rachelle L. Dawson, Alexander Lim, Susannah J. Tye, Fatima Ali Nasrallah · 2025 · Therapeutic Advances in Psychopharmacology
Mother's little helper turned a foe: Alprazolam use, misuse, and abuse
Astrid M. Cardona-Acosta, N Meisser, Nathan I. Vardeleon, Heinz Steiner, Carlos A. Bolaños‐Guzmán · 2024 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
It is Possible Find an Antidepressant with Faster Onset of Action? Ketamine: Promise or Reality?
Francisco Javier Lopez-Munoz, García-García, Cristerna González · 2014 · Depósito Digital e-UCJC
Investigating the Effect of Ginger as an Adjunctive Treatment along with SSRIs to Reduce Anxiety in Patients with GAD: A Clinical Trial Study
Sara Ataei, Leila Jahangard, Sina Anaraki, Dara Dastan, Salman Khazaei · 2023 · Current Psychiatry Research and Reviews
Updates on Preclinical and Translational Neuroscience of Mood Disorders
Nicholas Mischel, Michael D. Kritzer, Ashwin A. Patkar, Prakash S. Masand, Steven T. Szabo · 2019 · Journal of Clinical Psychopharmacology
Evaluation of Switch‐to‐Brand Rates as a Potential Signal for Therapeutic Equivalency of Generic Antidepressants: A Real‐World Retrospective Cohort Study
Shamir N. Kalaria, O’Mareen Spence, Kyungwan Hong, Susan dosReis, Mathangi Gopalakrishnan · 2021 · Clinical Pharmacology & Therapeutics
Preclinical evidence of a rapid-onset antidepressant-like effect of Pseudospondias microcarpa hydroethanolic leaf extract in a chronic depression model
Donatus Wewura Adongo, Priscilla Kolibea Mante, Kennedy Kwami Edem Kukuia, Eric Woode · 2016 · International Journal of Basic & Clinical Pharmacology
Serotonin – lipid interactions and their role in behavior
Liubov S. Kalinichenko, Erich Gulbins, Johannes Kornhuber, Christian P. Müller · 2020 · Handbook of behavioral neuroscience
Correlations between patterns of activity and the response to treatment yield distinct signatures for different antidepressive treatments
Stefan D. Spulber, Frederik Elberling, Sandra Ceccatelli, Martin Gärde, Mikael Tiger, Johan Lundberg · 2023 · medRxiv
Harnessing consumer wearable digital biomarkers for individualized recognition of postpartum depression using the All of Us Research Program dataset
Eric G. Hurwitz, Zachary Butzin-Dozier, Hiral Master, Shawn T. O’Neil, Anita Walden, Michelle Holko, Rena C. Patel, Melissa Anne Haendel · 2023 · medRxiv
Unlocking the Potential of Wear Time of a Wearable Device to Enhance Postpartum Depression Screening and Detection: Cross-Sectional Study
Eric G. Hurwitz, Samantha E Meltzer-Brody, Zachary Butzin-Dozier, Rena C. Patel, Noémie Elhadad, Melissa Anne Haendel · 2025 · JMIR Formative Research
Predicting antidepressant responsiveness in major depressive disorder patients via electroencephalography gamma-band dynamic functional connectivity in response to salient auditory stimuli
Kang‐Min Choi, Taegyeong Lee, Seung‐Hwan Lee, Chang‐Hwan Im · 2025 · The International Journal of Neuropsychopharmacology
From the gut to the brain: Potential novel avenues for IBD treatment via serotonergic pathways
Sara Ibgui, Daisy Lints, Simon W. F. Milling · 2025 · Pharmacological Research
Exploring the antidepressant-like effect of stigmasterol using network pharmacology with molecular docking and in vivo experimental validation
Robert Peter Biney, Isaac Blessed Mensah, Akua Afriyie Karikari, Aaron Opoku Antwi, Abigail Wortsi, Albert Dwamena Nkansah, Gyan Nana Kyere Barnieh, Isaac Tabiri Henneh · 2025 · Scientific Reports
miR-146a-3p drives major depressive disorder pathogenesis via BDNF suppression: a novel diagnostic and therapeutic target
Kangjun Sun, Tong Qin, Zhenhui Kang · 2026 · Gene
Palliative care in cardiovascular medicine
Endrit Cekaj, Frederik Sand, David H V Vogel, Peter Markus Spieth, Benedikt Schrage, Aitor Uribarri, Frederic De Roeck, Jordi Riera, Federico Pappalardo, Norman Mangner et al. · 2026 · European Heart Journal
Prevalence, median time, and associated factors with the likelihood of initial antidepressant change: a cross-sectional study in Qatar
Nervana Elbakary, Sami Ouanes, Sadaf Riaz, Oraib Abdallah, Islam Mahran, Noriya Al‐Khuzaei, Yassin Hassan Eltorki · 2021 · BMC Psychiatry
Changes in RNA expression levels during antidepressant treatment: a systematic review
Helena Kyunghee Kim, Gwyneth C. Zai, Johannes M. Hennings, Daniel J. Müller, Stefan M. Kloiber · 2021 · Journal of Neural Transmission
Optogenetic Animal Models of Depression: From Mice to Men
Ayla Arslan, Pınar Ünal‐Aydın, Taner Dogan, Orkun Aydın · 2022 · Neuromethods
Ethical Issues in Neuropsychopharmacotherapy: US Perspective
Michael J. Menconi, Veljko Dubljević · 2022 · Springer eBooks
Selecting Antidepressants Based on Medical History and Stress Mechanism
Hua Min, Farrokh Alemi, Janusz Wojtusiak · 2023 · Cureus
Utilization of Ketamine for Major Depression
Ryan Dao, Amit Aggarwal · 2023 · Journal of Exploratory Research in Pharmacology
Association of Pharmacologic Treatment of Depression/Anxiety With Initial Patient-Reported Outcome Measures in Patients With Hip and Knee Osteoarthritis
Alexander R. Farid, Adriana P. Liimakka, Emily Belle Parker, Jeremy T. Smith, Christopher M. Melnic, Antonia F. Chen, Jeffrey K. Lange · 2024 · Journal of the American Academy of Orthopaedic Surgeons
Reversibility of Neuropsychiatric Adverse Events after Switching to Darunavir/Cobicistat or Doravirine in Men on INSTI-Based Regimen
José Antonio Mata Marín, Carina Aurora Juárez-Contreras, Mara Soraya Rodríguez-Evaristo, Olivia Concepción Martínez-Carrizales, Ericka Nelly Pompa-Mera, Alberto Chaparro-Sánchez, Salma Triana-González, Ana Luz Cano-Díaz, Jesús Gaytán‐Martínez · 2024 · Viruses
The effect of antidepressant treatment on viral suppression among people with HIV diagnosed with depression in an urban clinic
Catherine R. Lesko, Anthony Todd Fojo, Heidi E. Hutton, Oluwaseun O Falade-Nwulia, Lauren C. Zalla, Marissa J. Seamans, Joyce L Jones, Nicholas P. Schweizer, Richard D. Moore, LaQuita N. Snow et al. · 2024 · AIDS
Comparative impact of exercise variants on depressive symptoms in cancer patients: A systematic review and network meta-analysis
Hao Zhang, Zeyong Hu, JIAO JIAN TONG, Jianhong Hu, Xinchao Wang, Bingnan Wang · 2024 · European Journal of Oncology Nursing
Coadministration of scopolamine and mGlu2 receptor negative allosteric modulator VU6001966 as a potential therapeutic approach for depression: Rat frontal cortex neurochemistry and behavior
Yana Babii, Agnieszka Pałucha-Poniewiera, Krystyna Gołembiowska, Agnieszka Bysiek, Izabela Szpręgiel, Andrzej Pilc · 2025 · Pharmacology Biochemistry and Behavior
A Report on the Antidepressant-like Activity of Paullinia pinnata Methanol Leaf Extract in Mice and Possible Involvement of Monoaminergic Mechanisms
Raymond Iduojemu Ozolua, Muideen A. Ajibade, Dickson Onyenmulo Uwaya, Abigail M. Akhigbemen, Israel Olapeju Bolanle · 2025 · Targets
Emerging role of microRNAs as novel targets of antidepressants
Aarthi Manoharan, Abialbon Paul · 2021 · Asian Journal of Psychiatry
Eficácia terapêutica da ayahuasca em pacientes com transtornos mentais baseada em estudos clínicos: uma revisão integrativa
Alexandre Machado de Moura, Marcela Barboza de Melo Aragão, Dário César de Oliveira Conceição, Karoline Belém Seixas · 2022 · Research Society and Development
Unlocking the potential of wearable device wear time to enhance postpartum depression screening and detection
Eric G. Hurwitz, Samantha E Meltzer-Brody, Zachary Butzin-Dozier, Rena C. Patel, Noémie Elhadad, Melissa Anne Haendel · 2024 · medRxiv
Heart rate variability during inpatient treatment of depression
Lennard Geiss, Beate Beck, Mark Stemmler, Thomas Hillemacher, K. Hösl · 2024 · Journal of mood and anxiety disorders
Using Smartphone Technology to Track Real-Time Changes in Anxiety/Depression Symptomatology Among Florida Cannabis Users
R. Nathan Pipitone, Benjamin Banai, Jessica Walters, Tyler Dautrich, Kelly L. Schuller, Martha S. Rosenthal · 2024 · Cannabis
Establishing Triple Chronotherapy as a fast-acting add-on treatment for unipolar and bipolar depression: evidence from an open-label randomized controlled trial in a real-world inpatient setting
Paolo Ferrara, Giovanni Broglia, Claudia Carrara, Simone Cavallotti, Barbara Giordano, Chiara Ossola, Hans‐Christian Stein, Stefano Terzoni, Edoardo Giuseppe Ostinelli, Stefano Masier et al. · 2025 · Journal of Affective Disorders
Rapid Development and Testing of Behavioral Text Message Reminders for Antidepressant Adherence via Online Panels: Survey Study
Tia R. Tropea, Steven C. Marcus, Amy Bucher, Cadence F. Bowden, Mark Olfson, Rebecca E. Stewart · 2026 · Journal of Medical Internet Research